Sudarshan Pharma Industries Ltd (SUDARSHAN) reported revenue of ₹174 Cr and net profit of ₹5.61 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
SUDARSHAN fundamentals, Fundamental score 68/100
The statements below are read from Sudarshan Pharma Industries Ltd’s filed results, 9 filed quarters and 7 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 12, 2026
Sales CAGR · 3Y+15.1%FY22 → FY25
Sales CAGR · 4Y+18.5%FY21 → FY25
PAT CAGR · 3Y+49.5%FY22 → FY25
PAT CAGR · 4Y+47.0%FY21 → FY25
Price · 1Y—EOD
Price CAGR · 3Y—EOD
Quarterly resultsConsolidated
₹ Cr
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
99.0
129
116
162
145
169
168
221
174
+20.1%
97.0
116
108
146
134
160
157
201
159
+18.1%
Operating profit
2.00
13.0
8.00
16.0
11.0
9.20
10.9
20.2
15.9
+44.0%
OPM %
2.0%
10.1%
6.9%
9.9%
7.6%
5.5%
6.5%
9.1%
9.1%
+1.5 pp
Other income
1.00
-1.00
1.00
-1.00
1.21
1.86
1.52
4.13
1.22
+1.1%
Interest
4.00
4.00
4.00
4.00
5.96
5.94
6.28
7.53
8.21
+37.8%
Depreciation
1.00
1.00
1.00
1.00
0.88
0.90
0.91
1.09
1.41
+59.2%
Profit before tax
-2.00
8.00
4.00
10.0
5.41
4.23
5.20
15.7
7.51
+38.8%
Tax %
n/a (loss)
25.0%
25.0%
30.0%
26.8%
8.4%
20.2%
27.5%
25.3%
-1.6 pp
Net profit
-1.00
6.00
3.00
7.00
3.96
3.87
4.15
11.4
5.61
+41.7%
EPS (₹)
-0.05
0.24
0.12
0.31
0.16
0.16
0.18
0.48
0.23
+43.8%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split · n/a (loss) = tax rate undefined on a loss↔ scroll for earlier quarters
Revenue & net profit trend
last 9 quarters
RevenueNet profit
Revenue & net profit — Consolidated9 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±3.5%· EPS surprise: no estimates source· 6 earlier quarters have no dated filing on record
Q1'27filed Wed 12 Aug 20:14 · first tradeable session Thu 13 Auggap +0.0%close +4.5%
